Alamar Biosciences, Inc.: 10% owner Qiming Corporate GP VI, Ltd. sold 342,626 shares

What happened

• The filing shows Qiming Corporate GP VI, Ltd., listed as a 10% owner, sold a total of 342,626 shares of Alamar Biosciences, Inc. in open-market or private sales on Oct 21 and Oct 22, 2026. Reported per-trade proceeds sum to $10,253,094.
• Individual reported trades include tranches such as 88,434 shares at $30.79 for $2,722,883 and 46,290 shares at $29.00 for $1,342,410; prices reported in the filing are sometimes weighted averages with ranges provided in footnotes.

Key details

• Transaction dates and prices: Oct 21, 2026 and Oct 22, 2026; per-trade prices reported between $28.33 and $31.23 (footnote ranges and some weighted-average prices are noted).
• Shares owned after the transactions: not stated in the provided filing excerpt.
• Footnotes of note: several entries use weighted-average prices with price ranges (e.g., $28.33 to $29.32; $29.33 to $30.17; $30.39 to $31.11; $30.41 to $31.23); certain shares are held of record by related funds (Qiming Managing Directors Fund VI, Qiming Venture Partners VI, QVP VIII LLC, QVP VIII-HC) and Qiming Corporate is described as general partner that may be deemed to have voting and dispositive power but disclaims beneficial ownership except for proportionate pecuniary interest.
• Filing date: Oct 23, 2026; the Form 4 was filed following the Oct 21–22, 2026 transactions (no late filing flag is indicated in the provided excerpt).

Why it may matter

• The filing records open-market or private sales (transaction code S), not option exercises or gifts.
• The reporting entity is a 10% owner (a large holder rather than an executive officer).
• A filing does not show why the insider traded or why the company acted.